Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

450
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
450
Infection01:20

Infection

8.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.9K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

245
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
245
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

210
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
210
History of Microbiology01:28

History of Microbiology

5.6K
Microbiology, a scientific field dedicated to the study of microorganisms, has undergone profound development since its inception in the 17th century. Its history is marked by key discoveries and technological advancements that have shaped our understanding of life at the microscopic level and transformed medicine, agriculture, and industry.Early Foundations of MicrobiologyThe early foundations of microbiology were built on groundbreaking observations and the development of pioneering...
5.6K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.7K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cerebral amyloid angiopathy-related inflammation and anti-amyloid immunotherapies].

Revue medicale suisse·2026
Same author

Factors associated with unawareness of HIV-positive status among individuals aged ≥ 15 years in Tanzania: Evidence from the Tanzania HIV Impact Survey 2022-2023.

BMC public health·2026
Same author

COVID-19 Vaccination in Adults: Results from the Tanzania HIV Impact Survey 2022-2023.

Vaccines·2025
Same author

[Jugular venous distention].

Revue medicale suisse·2025
Same author

Epidemiology, Risk Factors, and Outcomes of Neutropenic Enterocolitis in Onco-Hematological Patients According to Chemotherapy Regimen.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

[Pericarditis: state-of-the art and perspectives in 2025].

Revue medicale suisse·2025

Related Experiment Video

Updated: Oct 4, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

[Infectious diseases: Achievements, new Developments and Perspectives in 2021].

Fanny Blondet1, Oriane Aebischer1, Selin Tusgul1

  • 1Département de médecine, Ensemble hospitalier de la Côte, 1110 Morges.

Revue Medicale Suisse
|February 2, 2022
PubMed
Summary
This summary is machine-generated.

Advances in infectious disease prevention, diagnosis, and treatment continue despite challenges. This review covers new bacterial, viral, and fungal infection knowledge impacting clinical practices.

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.4K

Related Experiment Videos

Last Updated: Oct 4, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.4K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Significant progress in infectious disease management over recent decades.
  • Challenges include emerging infections, complex medical practices, and slow antimicrobial development.
  • The COVID-19 pandemic impacted 'medical normality' but did not halt medical advances.

Purpose of the Study:

  • To present new knowledge in bacterial, viral, and fungal infections.
  • To highlight findings that may alter hospital and ambulatory practices.
  • To provide an overview of recent scientific achievements in infectious diseases.

Main Methods:

  • Review of recent scientific literature and advancements.
  • Synthesis of information on bacterial, viral, and fungal pathogens.
  • Focus on clinically relevant findings impacting patient care.

Main Results:

  • Substantial progress in prevention, diagnosis, and treatment of infectious diseases.
  • Effective management of emerging infections and complications.
  • Continued medical advances despite global health crises.

Conclusions:

  • New knowledge in infectious diseases is poised to modify clinical practices.
  • Ongoing research is crucial for addressing infectious disease challenges.
  • Future articles will detail COVID-19 specific advancements.